Biocriminology and the Adjudication of Criminal Responsibility: Is There a Consensus Among Scientists' Verdicts?

August 15, 2022 updated by: Mia Athina Thomaidou, Leiden University Medical Center
Because of the evolving nature of psychology research, non-scientists are more likely to struggle or misinterpret evidence regarding a person's psychological state. Misconceptions may thus be highly prevalent within the justice system, leading to negative consequences for people with psychological or neurobiological disorders. At the same time, no research has been conducted to compare the punishment perspectives of non-scientists, that typically make sentencing decisions, to scientists who possess a more advanced understanding of human biology and behavior.

Study Overview

Status

Completed

Conditions

Detailed Description

In this study, closely inspired by the paradigms of Berryessa, Coppola, and Salvato, perspectives on punishment based on psychobiological explanations of behaviour are assessed, aiming to understand how scientists with knowledge of human psychobiology versus lay people (of similar educational level) interpret offending behaviour. Human-science is contrasted to natural-science/arts graduates because the former have been exposed to and may possess scientific knowledge that shapes their understanding of behaviour, their views, and potential (essentialist) biases. In contrast, non-scientists have been found to possess scientific misconceptions that can impact their sentencing decisions. This leads to the question whether scientists may draw different judgements based on their professional knowledge and experience with psychological phenomena. If indeed scientists with greater insight on human behaviour are found to hold less punitive views on punishment and rehabilitation, that has important implications for criminal justice systems that rely on lay peoples' understanding of science.

One hundred sixty participants who completed all study procedures (2 main groups of 80 participants) will be surveyed. A sample size calculation was performed using G*Power version 3.1.9.4, based on Berryessa and colleagues who conducted a similar survey study in 2021 with comparable outcome measures and analyses. The required effect size is based upon approximately 3-4 outcome measures. The primary research question is between-groups, while secondary ones include within groups measures. Based on the power analysis, a sample of 160 participants will be targeted, which is enough for sufficient power for f = 0.25, power = 0.80, df = 4, for 2 different groups.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Holland
      • Leiden, South Holland, Netherlands, 2333 AK
        • Leiden University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged between 18 and 65
  • Holding a university diploma or equivalent

Exclusion Criteria:

  • Participants who did not complete the survey (appropriately) will be excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Human Science
Arm 1 will include university graduates that hold at least a science undergraduate degree (or equivalent) in human science, including psychology, neuroscience, human biology, or medicine.
Participants in each of the two main groups see a case with and a case without a neurobiological explanation for criminal offending.
Active Comparator: Natural or non-science
Arm 2 will include university graduates from non-human or non-scientific fields such as engineering, history, language studies, or law.
Participants in each of the two main groups see a case with and a case without a neurobiological explanation for criminal offending.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sentencing severity on 5-point questionnaire
Time Frame: Immediately after case presentation, an average of 1 minute.
This is the primary outcome measure of attitudes towards sentencing, measured via a questionnaire on a visual analogue scale from 1 (only treatment) to 5 (more than 5 years in prison)
Immediately after case presentation, an average of 1 minute.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2021

Primary Completion (Actual)

July 1, 2022

Study Completion (Actual)

July 1, 2022

Study Registration Dates

First Submitted

August 2, 2021

First Submitted That Met QC Criteria

August 10, 2021

First Posted (Actual)

August 16, 2021

Study Record Updates

Last Update Posted (Actual)

August 16, 2022

Last Update Submitted That Met QC Criteria

August 15, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-07-16-D.S.V.-V2-3332

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Raw anonymised data, processing and analysis steps, and all code, will be provided via an online repository or as required by a scientific journal.

IPD Sharing Time Frame

After the publication of the study

IPD Sharing Access Criteria

For quality assurance and potential use in relevant research when deemed applicable

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Criminalism

Clinical Trials on Biocriminological Evidence

3
Subscribe